MedTrace Logo

Evaluation of Extended Wear Technology

NCT04882800 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-12-14

Study results available
· View outcomes & findings →

Summary

Evaluating the efficacy and effectiveness of an advancement in the fitting characteristics of extended wear technology with the commercially available device as a comparator.

Conditions

Interventions

DEVICE

Lyric extended wear hearing aid device A

Current commercially available extended wear hearing aid

DEVICE

Lyric extended wear hearing aid with fitting modification device B

Extended wear hearing aid with fitting modifications

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Kevin Seitz-Paquette, AuD · Sonova AG

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-08
Primary Completion
2021-05-31
Completion
2021-06-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04882800 on ClinicalTrials.gov